Analyst Ratings For
Acadia Healthcare Company Inc (NASDAQ:ACHC)
Today, UBS Group raised its price target on
Acadia Healthcare Company Inc (NASDAQ:ACHC) to $34.00 per share.
There are 7 Hold Ratings, 3 Buy Ratings, no Strong Buy Ratings, no Sell Ratings on the stock.
The current consensus rating on
Acadia Healthcare Company Inc (NASDAQ:ACHC) is Hold with a consensus target price of $37.1111 per share, a potential 13.28% upside.
Some recent analyst ratings include
- 7/31/2019-
Acadia Healthcare Company Inc (NASDAQ:ACHC) gets downgraded to Outperform by Raymond James with a price target of $45.00
- On 9/5/2019 Debra K Osteen, CEO, bought 20,000 with an average share price of $26.53 per share and the total transaction amounting to $530,600.00.
- On 11/1/2018 Reeve B Waud, Director, sold 41,865 with an average share price of $45.00 per share and the total transaction amounting to $1,883,925.00.
- On 7/26/2018 Reeve B Waud, Director, sold 8,135 with an average share price of $45.00 per share and the total transaction amounting to $366,075.00.
- On 3/15/2018 Reeve B Waud, Director, sold 7,698 with an average share price of $42.03 per share and the total transaction amounting to $323,546.94.
- On 3/14/2018 Randall P Goldberg, VP, sold 400 with an average share price of $41.47 per share and the total transaction amounting to $16,588.00.
- On 3/13/2018 Reeve B Waud, Director, sold 42,302 with an average share price of $42.02 per share and the total transaction amounting to $1,777,530.04.
- On 3/6/2018 Reeve B Waud, Director, sold 200,000 with an average share price of $39.02 per share and the total transaction amounting to $7,804,000.00.
Recent Trading Activity for
Acadia Healthcare Company Inc (NASDAQ:ACHC)
Shares ofAcadia Healthcare Company Inc closed the previous trading session at with 33 shares trading hands.
